XL-protein signs licensing agreement with International Biotechnology Center Generium - MarketLine Financial Deals

XL-protein signs licensing agreement with International Biotechnology Center Generium

XL-protein signs licensing agreement with International Biotechnology Center Generium - MarketLine Financial Deals
XL-protein signs licensing agreement with International Biotechnology Center Generium
Published Jun 25, 2013
2 pages — Published Jun 25, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

XL-protein GmbH, a Germany-based biotech company that focuses on preclinical and clinical development of PASylated proteins, has entered into license and collaboration agreement with International Biotechnology Center Generium.

  
Source:
Document ID
MA140232_130703
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "XL-protein signs licensing agreement with International Biotechnology Center Generium" Jun 25, 2013. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/XL-protein-signs-licensing-agreement-with-International-Biotechnology-Center-Generium-2052-95766>
  
APA:
MarketLine Financial Deals. (2013). XL-protein signs licensing agreement with International Biotechnology Center Generium Jun 25, 2013. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/XL-protein-signs-licensing-agreement-with-International-Biotechnology-Center-Generium-2052-95766>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.